经皮球囊肺动脉成形术治疗慢性血栓栓塞性肺动脉高压的研究进展  

Research progress on percutaneous balloon pulmonary angioplasty in the treatment of chronic thromboembolic pulmonary hypertension

作　　者：李扬 刘岩 苏丕雄 安向光 顾松 杨苏乔[2] Li Yang;Liu Yan;Su Pixiong;An Xiangguang;Gu Song;Yang Suqiao(Heart Center and Beijing Key Laboratory of Hypertension,Beijing Chao-yang Hospital,Capital Medical University,Beijing 100020,China;Department of Respiratory Medicine,Beijing Chao-yang Hospital,Capital Medical University,Beijing 100020,China)

机构地区：[1]首都医科大学附属北京朝阳医院心脏中心高血压病研究北京市重点实验室,100020 [2]首都医科大学附属北京朝阳医院呼吸内科,100020

出　　处：《中国医药》2021年第12期1899-1902,共4页China Medicine

基　　金：国家自然科学基金(81900047)。

摘　　要：慢性血栓栓塞性肺动脉高压(CTEPH)是一类肺动脉梗阻性疾病,其病因较复杂,主要为血栓栓塞导致肺动脉堵塞,肺部血管结构改变,进而产生肺动脉高压。肺动脉内膜剥脱术是CTEPH的首选治疗方法。随着介入治疗的发展,经皮球囊肺动脉成形术逐渐成为无法行肺动脉内膜剥脱术、术后仍持续肺动脉高压或复发患者的一种新选择。本文对经皮球囊肺动脉成形术治疗CTEPH的研究进展进行综述。Chronic thromboembolic pulmonary hypertension(CTEPH)is a group of pulmonary artery obstructive disease.The pathogeny is complex,mainly due to pulmonary artery blockage caused by thromboembolism,changes in pulmonaty vascular structure,and then leads to pulmonary hypertension(PH).The primary treatment for CTEPH is pulmonary endarterectomy(PEA).For patients ineligible for PEA or have recurrent or persistent PH after surgery,percutaneous balloon pulmonary angioplasty(BPA)is an emerging option with the development of interventional treatment.This article reviews the research progress on BPA in the treatment of CTEPH.

关 键 词：慢性血栓栓塞性肺动脉高压 经皮球囊肺动脉成形术 

分 类 号：R543.2[医药卫生—心血管疾病]